Global Central Vascular Access Device Market Size By Type (PICC, Centrally Inserted Catheters), By Application (Hospital, Non-Hospital), By Region, And Segment Forecasts, 2023 to 2032

The Global Central Vascular Access Device Market was valued at USD 5.9 billion in 2023 and is expected to surpass USD 9.4 billion by 2031, expanding at a CAGR of 6.1% during the forecast period from 2023 to 2031. Central vascular access devices (CVADs) are critical in administering medications, fluids, parenteral nutrition, and for blood sampling in critically ill patients. The increasing prevalence of chronic diseases such as cancer, kidney failure, and cardiovascular conditions, along with a rising geriatric population and expanding surgical procedures worldwide, is fueling market growth. The shift towards minimally invasive procedures and the adoption of advanced technologies in catheter design are further supporting the market's positive trajectory.

Drivers:

Rising Incidence of Chronic Diseases:

With a global surge in chronic illnesses like cancer, diabetes, and end-stage renal disease, there is a growing need for prolonged intravenous therapies. This directly boosts the demand for CVADs, which offer safe, long-term vascular access.

Technological Innovations in Catheter Materials and Design:

Advancements in catheter technology, including antimicrobial coatings and power-injectable catheters, have enhanced device longevity and reduced infection risks, driving widespread adoption in hospitals and outpatient centers.

Growing Surgical and ICU Admissions:

The increased number of complex surgeries and intensive care unit (ICU) admissions globally has augmented the use of CVADs, particularly in the administration of critical care medications and total parenteral nutrition.

Restraints:

Risks of Catheter-Related Infections and Complications:

Despite technological improvements, complications such as bloodstream infections, thrombosis, and mechanical dysfunction remain prevalent, hindering broader adoption, particularly in resource-limited settings.

High Cost of Advanced Devices:

The cost associated with advanced CVADs and the necessary supporting infrastructure, such as imaging for placement, can be a barrier in underfunded healthcare systems, especially in low- and middle-income countries.

Opportunity:

Expansion in Emerging Healthcare Markets:

Rapid improvements in healthcare infrastructure and rising awareness of advanced medical devices in countries like India, Brazil, and Indonesia present strong opportunities for market players.

Development of Home-Based and Portable Infusion Therapies:

With healthcare moving toward outpatient and home-care models, the demand for user-friendly and safe vascular access devices is growing, particularly for patients requiring long-term treatments.

Market by System Type Insights:

The Peripherally Inserted Central Catheters (PICCs) segment dominated the market in 2023. Their relatively easy insertion, reduced infection risk, and suitability for long-term intravenous therapy have made them a preferred choice, especially in oncology and home infusion settings.

Meanwhile, Implantable Ports are expected to witness notable growth due to their use in chemotherapy and chronic illness management, offering convenience and a reduced maintenance burden over time.

Market by End-use Insights:

In 2023, Hospitals held the largest market share, driven by a high volume of inpatient care, surgeries, and ICU admissions requiring central vascular access. Home Healthcare is expected to grow at the fastest rate during the forecast period, propelled by the rise of remote care solutions and preference for cost-effective outpatient treatments.

Market by Regional Insights:

North America led the market in 2023, attributed to well-established healthcare systems, high healthcare expenditure, and early adoption of advanced medical technologies. Asia-Pacific is anticipated to experience the fastest growth, fueled by rising healthcare access, increasing chronic disease burden, and government investment in medical infrastructure.

Competitive Scenario:

Key players operating in the global central vascular access device market include:

Becton, Dickinson and Company

Teleflex Incorporated

B. Braun Melsungen AG

Smiths Medical

ICU Medical, Inc.

AngioDynamics, Inc.

Vygon Group

Cook Medical

Medtronic plc

Fresenius Medical Care AG & Co. KGaA

These companies are focusing on strategic acquisitions, R&D for novel catheter materials, and global expansion to strengthen their market position.

Scope of Work – Global Central Vascular Access Device Market

Report Metric Details

Market Size (2023) USD 5.9 billion

Projected Market Size (2031) USD 9.4 billion

CAGR (2023–2031) 6.1%

Market Segments By System Type (PICCs, Central Venous Catheters, Implantable Ports, etc.), By End-use (Hospitals, Ambulatory Surgical Centers, Home Healthcare), By Region

Growth Drivers Rising chronic disease incidence, Technological innovation in catheter design, Growing ICU and surgical demand

Opportunities Expansion in emerging markets, Rise of home-based infusion therapy

Key Market Developments:

In 2023, Becton, Dickinson and Company introduced a new antimicrobial central venous catheter designed to minimize infection rates in ICU settings.

ICU Medical, Inc. completed its acquisition of Smiths Medical in 2022, strengthening its position in the vascular access market.

Teleflex announced in 2024 a strategic partnership with a major hospital network in Europe to supply PICCs for oncology treatment centers.

FAQs:

1) What is the current market size of the Global Central Vascular Access Device Market?

The market was valued at USD 5.9 billion in 2023.

2) What is the major growth driver of the Global Central Vascular Access Device Market?

The key driver is the increasing incidence of chronic diseases requiring long-term intravenous therapy.

3) Which is the largest region during the forecast period in the Global Central Vascular Access Device Market?

North America is the largest region due to high healthcare expenditure and advanced medical infrastructure.

4) Which segment accounted for the largest market share in Global Central Vascular Access Device Market?

The Peripherally Inserted Central Catheters (PICCs) segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Central Vascular Access Device Market?

Key players include Becton, Dickinson and Company, Teleflex Incorporated, B. Braun Melsungen AG, Smiths Medical, and ICU Medical, Inc.